← FDA Drug Approvals (Drugs@FDA)

EVOXAC

NDA · New Drug Application · Sponsor: COSETTE PHARMS NC · Approved 2026-10-15

Drug application

FDA Application #

NDA221183

Application type

New Drug Application

Brand name

EVOXAC

Generic name

Cevimeline Hydrochloride

Active ingredients

CEVIMELINE HYDROCHLORIDE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

COSETTE PHARMS NC

First approval

2026-10-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown